1. Home
  2. GNLN vs PPCB Comparison

GNLN vs PPCB Comparison

Compare GNLN & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$0.31

Market Cap

1.6M

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.11

Market Cap

1.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
PPCB
Founded
2005
2007
Country
United States
Australia
Employees
N/A
2
Industry
Durable Goods
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
GNLN
PPCB
Price
$0.31
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
284.6K
1.2M
Earning Date
05-14-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
21.57
N/A
EPS
N/A
N/A
Revenue
$13,275,000.00
N/A
Revenue This Year
$1,541.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.10
52 Week High
$7.73
$10.69

Technical Indicators

Market Signals
Indicator
GNLN
PPCB
Relative Strength Index (RSI) 28.41 34.60
Support Level N/A N/A
Resistance Level $0.89 $0.40
Average True Range (ATR) 0.12 0.01
MACD -0.02 0.01
Stochastic Oscillator 10.01 40.50

Price Performance

Historical Comparison
GNLN
PPCB

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: